JP5933633B2 - サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤 - Google Patents

サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤 Download PDF

Info

Publication number
JP5933633B2
JP5933633B2 JP2014125633A JP2014125633A JP5933633B2 JP 5933633 B2 JP5933633 B2 JP 5933633B2 JP 2014125633 A JP2014125633 A JP 2014125633A JP 2014125633 A JP2014125633 A JP 2014125633A JP 5933633 B2 JP5933633 B2 JP 5933633B2
Authority
JP
Japan
Prior art keywords
sirt1
sirtuin
agent
activator
gene transcription
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014125633A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014185170A (ja
JP2014185170A5 (enExample
Inventor
田沼　靖一
靖一 田沼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APION JAPAN CO., LTD.
Original Assignee
APION JAPAN CO., LTD.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by APION JAPAN CO., LTD. filed Critical APION JAPAN CO., LTD.
Priority to JP2014125633A priority Critical patent/JP5933633B2/ja
Publication of JP2014185170A publication Critical patent/JP2014185170A/ja
Publication of JP2014185170A5 publication Critical patent/JP2014185170A5/ja
Application granted granted Critical
Publication of JP5933633B2 publication Critical patent/JP5933633B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
JP2014125633A 2014-06-18 2014-06-18 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤 Active JP5933633B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014125633A JP5933633B2 (ja) 2014-06-18 2014-06-18 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014125633A JP5933633B2 (ja) 2014-06-18 2014-06-18 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011259573A Division JP5608629B2 (ja) 2011-11-28 2011-11-28 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤

Publications (3)

Publication Number Publication Date
JP2014185170A JP2014185170A (ja) 2014-10-02
JP2014185170A5 JP2014185170A5 (enExample) 2015-01-29
JP5933633B2 true JP5933633B2 (ja) 2016-06-15

Family

ID=51833061

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014125633A Active JP5933633B2 (ja) 2014-06-18 2014-06-18 サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤

Country Status (1)

Country Link
JP (1) JP5933633B2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106822152B (zh) * 2016-12-28 2019-12-13 哈尔滨珍宝制药有限公司 一种药物组合物及其应用
CN110343045B (zh) * 2019-08-13 2021-11-12 中国科学院成都生物研究所 芳基四氢萘型木脂素类化合物及制备和应用
US20240033303A1 (en) * 2020-12-08 2024-02-01 Md Healthcare Inc. Composition for preventing or treating neurological diseases or psychiatric diseases comprising vesicles derived from sphingomonas bacteria

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2784605B2 (ja) * 1990-04-28 1998-08-06 靖一 田沼 リグニン配糖体およびその用途
JP2010540444A (ja) * 2007-09-20 2010-12-24 レスベラトロル パートナーズ， エルエルシー 遺伝子産物の濃縮または活性を調節するためのレスベラトロールを含む組成物

Also Published As

Publication number Publication date
JP2014185170A (ja) 2014-10-02

Similar Documents

Publication Publication Date Title
JP5608629B2 (ja) サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤
KR101966294B1 (ko) 감태 추출물과 괭생이모자반 추출물을 이용한 항염증용 조성물
JP2023525322A (ja) 新規のアッカーマンシア・ムシニフィラａｋ３２菌株の発見および腸損傷の予防または治療のための応用
JP5813576B2 (ja) サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤
KR102178926B1 (ko) 발효 태반 조성물을 유효성분으로 하는 면역 증강 또는 항피로 조성물과 그의 용도
JP5948139B2 (ja) サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤
JP2014185170A (ja) サーチュイン１（ｓｉｒｔ１）遺伝子活性化剤及びテロメラーゼ逆転写酵素（ｔｅｒｔ）遺伝子活性化剤
JP2022183626A (ja) ミクログリア活性化抑制剤
KR101471287B1 (ko) 스피룰리나 맥시마 유래의 펩타이드를 유효성분으로 포함하는 알러지 관련 질환의 예방 또는 치료용 조성물
KR101666524B1 (ko) 초과(Amomi Tsao-ko)로부터 분리된 화합물 및 이의 항염 용도
RU2423139C2 (ru) КОМПОЗИЦИИ, СОДЕРЖАЩИЕ Actinidia, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
KR101798586B1 (ko) 백미 추출물을 포함하는 아토피 피부염 치료용 조성물
KR101520533B1 (ko) 스피룰리나 맥시마 유래의 펩타이드를 유효성분으로 포함하는 심혈관 질환의 예방 또는 치료용 조성물
JP2004002284A (ja) リウマチの症状改善用飲食品および医薬
JP2007137775A (ja) 破骨細胞分化抑制因子（ｏｐｇ）産生促進用組成物
JP5076104B2 (ja) アレルギー体質改善剤
KR101851639B1 (ko) 모과 추출물 또는 이의 분획물을 유효성분으로 함유하는 항비만용 조성물
KR101790409B1 (ko) 지구자 추출물을 유효성분으로 포함하는 항비만용 조성물
JP7428991B2 (ja) 糖の吸収抑制用剤
JP2022104122A (ja) オキシトシン関連シグナル活性化剤
KR102617562B1 (ko) 우도 땅콩 새싹 추출물을 유효성분으로 함유하는 근감소증의 개선, 예방 또는 치료용 조성물
KR101499286B1 (ko) 시난디온 ａ를 포함하는 항염증용 조성물
KR100842054B1 (ko) 구운감초 추출물 또는 이로부터 분리한 화합물을 포함하는혈당 강하용 조성물
KR102318957B1 (ko) 진세노사이드 mc 또는 mc1을 포함하는 대사성 질환 예방 또는 치료용 조성물
JP2017095409A (ja) 筋萎縮阻害剤及びこれを含む食品並びに医薬品

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141128

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141209

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151006

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20151207

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160405

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160502

R150 Certificate of patent or registration of utility model

Ref document number: 5933633

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250